The Effect of Mesotherapy and Intra-articular Steroid Injection in Shoulder Pain
CompletedNot applicableNCT06610032
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Patients with chronic shoulder pain will be divided randomly into mesotherapy and intra-articular steroid injection groups. Pain severity, range of motion and functional impairment will evaluated before treatment, 30 minutes and 4 weeks after the injections.
Study details
- Official title
- The Comparison o the Efficacy of Mesotherapy and Intra-articular Steroid Injection in Patients With Chronic Shoulder Pain
- Conditions
- Interventions
- Procedure: Mesotherapy
- Procedure: Intra-articular steroid injection
- Sponsor
- Haydarpasa Numune Training and Research Hospital
- Start date
- 2024-07-01
- Primary completion
- 2024-09-01
- Sex
- All
- Age range
- from 18 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Ages 18-75 2. Having shoulder pain for 6 months 3. VAS (Visual Analog Scale) \> 4 4. Patients who can receive verbal instructions and do not have cognitive deficits Exclusion Criteria: 1. Physical therapy applied to the shoulder area in the last 3 months 2. Having had a shoulder joint injection in the last 3 months 3. History of previous upper extremity surgery 4. History of drug allergy 5. Use of anticoagulant drugs (warfarin, low molecular weight heparin), patients with coagulation disorder 6. History of malignancy 7. Psychiatric illness 8. A rheumatological diagnosis such as Polymyalgia Rheumatica, Rheumatoid Arthritis, Ankylosing Spondylitis 9. Kidney failure 10. Liver disease 11. Heart failure 12. Pregnancy 13. Presence of infection, wound, allergy, burn-like lesions in the application area
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06610032